Jiangsu Hengrui Pharmaceuticals (01276) transferred the repurchased 13.5111 million A shares to the employee stock ownership plan.
Hengrui Medicine (01276) announced that on November 7, 2025, it will have repurchased 13.5111 million...
Jiangsu Hengrui Pharmaceuticals (01276) announced on November 7, 2025, that the 13.5111 million repurchased A-shares will be transferred to the employee share ownership plan.
Related Articles
Happy Comfort (02698): Hong Kong's public offering was oversubscribed 1813.77 times and is expected to be listed on November 10th.
AOM INT'L (00381) plans to issue 59 million Hong Kong dollars worth of convertible bonds to acquire a 72.5% stake in Jiangxi Jiu Ai Food Co., Ltd.
HAOHAI BIOTEC (06826) plans to acquire the remaining 20% equity interest of Shenzhen New Industries Biomedical Engineering Ophthalmic New Technology Co., Ltd. for 74 million yuan.
Happy Comfort (02698): Hong Kong's public offering was oversubscribed 1813.77 times and is expected to be listed on November 10th.
AOM INT'L (00381) plans to issue 59 million Hong Kong dollars worth of convertible bonds to acquire a 72.5% stake in Jiangxi Jiu Ai Food Co., Ltd.
HAOHAI BIOTEC (06826) plans to acquire the remaining 20% equity interest of Shenzhen New Industries Biomedical Engineering Ophthalmic New Technology Co., Ltd. for 74 million yuan.
RECOMMEND
Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025
Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025
Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025
